Artificial Intelligence and Health: Piedmont Becomes a Global Hub for the Diagnostics of the Future

Monday, June 29, 2026, starting at 10:00 AM, the Romantic Hotel Furno in San Francesco al Campo will host the institutional conference “Artificial Intelligence: from radiology to global scenarios”, organized by the Centro Diagnostico Studio Futura of Ciriè and by Health Triage, under the patronage of Confindustria Canavese.

The event was born to address an increasingly urgent need: governing the digital transition in healthcare. Over the last ten years, the demand for diagnostic services has grown significantly, with an estimated increase of 60% for MRI scans alone. This growth is driven by an ageing population, the rise of chronic diseases and advances in oncology, all requiring ever more frequent check-ups. The result is a system under pressure, with hospitals and private facilities struggling with increasingly long waiting lists. In this scenario, Artificial Intelligence is emerging as a decisive ally: it supports radiologists in image reading, speeds up workflows, reduces examination times and helps filter inappropriate requests. These premises will set the stage for a dialogue between institutions, clinicians and academia.

The conference will open with institutional greetings from Claudia Porchietto (Undersecretary to the Presidency of the Piedmont Region), Federico Riboldi (Regional Councillor for Health, Piedmont), Loredana Devietti Goggia (Mayor of Ciriè) and Filippo Molinari (Deputy Rector for Strategic Planning, Politecnico di Torino).

The multidisciplinary panel will explore the key drivers of innovation:

  • Gino Carnazza (specialist in radiodiagnostics) will address the human-machine synergy. Thanks to deep learning systems, AI acts as a digital assistant capable of identifying complex lesions at an early stage, optimising clinical workflows and freeing up quality time for patient care.
  • Daniele Regge (radiologist at the Candiolo Institute, FPO-IRCCS) will explore the concept of the “radiology of the future” and the development of patient “digital twins”. These virtual models will make it possible to understand disease progression and personalise therapies, placing the radiologist at the centre of clinical data management.
  • Giovanna Marzo (Associate Professor of Private Law, cassation lawyer, President of Auxilia Iuris) will analyse the legal risks of AI in healthcare, examining algorithmic autonomy and the difficulty of attributing liability. After reviewing the European regulatory framework, she will assess whether traditional legal categories are still adequate or whether AI requires a revision of protective tools, balancing innovation, rights and the principle of legitimate expectation.
  • Riccardo Zecchina (Professor of Theoretical Physics, Director of the AI Lab at Bocconi University) will close the debate by exploring generative AI, where text, images and sound converge towards a representation of the world capable of integrating robotics as a concrete new promise for advanced diagnostics.

“Health Triage’s participation in this regional dialogue” — states Davide Dettori, CEO of the company — “confirms our commitment to contributing to the local debate on new healthcare technologies. Born and rooted in Turin, we intend to bring our contribution to foster a dialogue in which technology is seen as the doctor’s ally, for a more human, effective and rigorously ethical precision medicine.”

“Our experience in integrating advanced diagnostic systems confirms Studio Futura’s commitment to strengthening the effectiveness of clinical radiology,” underlines Dr. Gino Carnazza, Medical Coordinator of the Centro Radiodiagnostico Studio Futura in Ciriè. “For years we have combined specialist expertise with artificial intelligence tools for mammography, chest X-ray and gynaecological diagnostics, with the aim of detecting lesions and formations that are difficult to identify with the human eye alone. This approach also involves the facility’s main equipment, from the Dual Energy CT to MRI, increasingly oriented towards improving the reliability and quality of examinations. Technology thus proves to be an essential ally for more precise and timely medicine.”

At the end of the presentations, the discussion will continue by analysing how the integration of these systems can reduce clinical research timelines and overcome the limitations of traditional screening. The presence in Piedmont of centres of excellence in independent clinical research and cutting-edge technology companies confirms the region’s potential as a permanent laboratory for the digital healthcare of the future.


About Health Triage

Health Triage S.p.A. is an innovative start-up established in early 2020, controlled by Fin Posillipo S.p.A. and also backed by the ENEA Tech e Biomedical Foundation. Fin Posillipo S.p.A. oversees more than thirty companies with offices in Italy and Spain, serving Europe, North Africa, the Middle East, Latin America, the Far East and Oceania. The Group carries out research, development and commercialisation activities in the healthcare sector through its subsidiaries, with a turnover of €800 million and more than 800 employees, providing direct support to Clinical Research Organisations for clinical analyses, research projects, scientific testing and pre-launch activities. Current research activities focus primarily on the development of new technologies for automatic oncological diagnosis, with a particular focus on the prevention and diagnosis of prostate cancer.

About Studio Futura

Studio Futura is a Medical Radiology Centre active since 2010 in Ciriè (TO), chosen by patients from across the province of Turin. It offers diagnostic services including conventional radiology, dental CT radiology, mammography, bone densitometry, ultrasound, CT and MRI. Modern technology, skilled staff and patient-centred care are the hallmarks of the service provided.


Press Office – Health Triage:
Francesco Signor | Mobile: +39 335 7864927 | Email: press@healthtriage.ai
www.healthtriage.ai | www.studiofutura.com

Altri articoli

Screening mammografico e IA

Health Triage sarà presente al Congresso Nazionale del GISMa (Gruppo Italiano Screening Mammografico), in programma presso l’AURUM di Pescara dal 20 al 22 maggio 2026. L’evento rappresenta il principale punto di riferimento per la sanità pubblica dedicata alla prevenzione senologica e si focalizzerà quest’anno sulle integrazioni tecnologiche e organizzative dei...

Screening senologico

Siglato l’accordo per la validazione clinica su 75.000 donne: l’obiettivo è potenziare la prevenzione nazionale attraverso il “triage intelligente” che ottimizza il lavoro dei radiologi e accelera le diagnosi. TORINO 12 febbraio 2026 – Con l’introduzione delle nuove linee guida sull’IA applicata alla prevenzione a fine 2025, l’Italia rafforza il...

Screening senologico e IA

L’Intelligenza Artificiale entra nel vivo dello screening mammografico organizzato. Su La Repubblica, all’interno dello speciale Salute, la dott.ssa Francesca Caumo, Vice presidente del GISMa (Gruppo Italiano Screening Mammografico), approfondisce le sfide e le opportunità legate all’integrazione delle nuove tecnologie nei percorsi di prevenzione. Al centro il grande studio prospettico multicentrico,...

Diagnosi del carcinoma prostatico

Il 26 e 27 marzo 2026, Health Triage partecipa come sponsor al corso “Diagnosi, Staging e Gestione Multidisciplinare del Carcinoma Prostatico: i GOM Toscani fanno Rete”. L’evento, che si terrà presso il Grand Hotel Mediterraneo di Firenze, rappresenta un momento di confronto strategico tra i coordinatori delle reti oncologiche regionali...

Prevenire il tumore al seno con l’IA

Il tumore al seno, grazie all’efficacia dei programmi di prevenzione, è la neoplasia più diagnosticata al mondo, ma rappresenta ancora la principale causa di mortalità oncologica nella popolazione femminile. L’Intelligenza Artificiale è già entrata nel mondo della salute, mossa dal “saper fare” e dal coraggio di tanti professionisti italiani. Di...

Lo studio svedese su The Lancet conferma l'efficacia dell'Intelligenza Artificiale 

I risultati definitivi dello studio MASAI, pubblicati sulla rivista The Lancet e ripresi dalle principali testate internazionali come The Guardian, segnano una svolta nel campo della diagnostica oncologica. Il trial randomizzato, che ha coinvolto oltre centomila donne in Svezia, dimostra che l’integrazione dell’IA nel workflow di screening non solo è...

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.